• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

COVID-19 肺炎的有限尸检肺组织病理学改变:炎症和血栓形成的传奇。

Pathological changes in COVID-19 pneumonia on limited post-mortem sampling of lung: A saga of inflammation and thrombosis.

机构信息

Department of Pulmonary Medicine, AIIMS Bhopal, Bhopal, Madhya Pradesh, India.

Department of CTVS, AIIMS Bhopal, Bhopal, Madhya Pradesh, India.

出版信息

Indian J Pathol Microbiol. 2022 Jul-Sep;65(3):653-656. doi: 10.4103/IJPM.IJPM_1158_20.

DOI:10.4103/IJPM.IJPM_1158_20
PMID:35900495
Abstract

We describe three postmortem open lung-biopsy findings among patients with COVID-19 pneumonia who were on anticoagulant therapy. The spectrum of histopathological findings included lung inflammation in the form of diffuse alveolar damage (DAD) in exudative and organizing phases, with or without pulmonary artery thrombosis in different stages of evolution. This spectrum of inflammation and thrombosis may be indicative of a natural history of severe COVID-19 pneumonia or demonstrative of variation in therapeutics.

摘要

我们描述了 COVID-19 肺炎患者在抗凝治疗下进行的三次死后开胸肺活检的发现。组织病理学发现的范围包括渗出性和机化性弥漫性肺泡损伤(DAD)形式的肺部炎症,伴有或不伴有不同演变阶段的肺动脉血栓形成。这种炎症和血栓形成的范围可能提示严重 COVID-19 肺炎的自然病程,或者表明治疗方法的差异。

相似文献

1
Pathological changes in COVID-19 pneumonia on limited post-mortem sampling of lung: A saga of inflammation and thrombosis.COVID-19 肺炎的有限尸检肺组织病理学改变:炎症和血栓形成的传奇。
Indian J Pathol Microbiol. 2022 Jul-Sep;65(3):653-656. doi: 10.4103/IJPM.IJPM_1158_20.
2
Tracking the time course of pathological patterns of lung injury in severe COVID-19.追踪严重 COVID-19 中肺损伤的病理模式的时间进程。
Respir Res. 2021 Jan 29;22(1):32. doi: 10.1186/s12931-021-01628-9.
3
Pulmonary post-mortem findings in a series of COVID-19 cases from northern Italy: a two-centre descriptive study.意大利北部一系列 COVID-19 病例的肺脏尸检结果:一项两中心描述性研究。
Lancet Infect Dis. 2020 Oct;20(10):1135-1140. doi: 10.1016/S1473-3099(20)30434-5. Epub 2020 Jun 8.
4
Morphological prediction of lethal outcomes in the evaluation of lung tissue structural changes in patients on respiratory support with СOVID-19: Ukrainian experience.在使用 COVID-19 呼吸支持的患者的肺组织结构变化评估中,对致死结果的形态学预测:乌克兰经验。
Pathol Res Pract. 2023 May;245:154471. doi: 10.1016/j.prp.2023.154471. Epub 2023 Apr 23.
5
Postmortem lung biopsies from four patients with COVID-19 at a tertiary hospital in Cape Town, South Africa.南非开普敦一家三级医院的 4 名 COVID-19 患者的死后肺活检。
S Afr Med J. 2020 Oct 19;110(12):1195-1200. doi: 10.7196/SAMJ.2020.v110i12.15290.
6
Pathological Lung Patterns of COVID-19 and its Clinical Correlation to Disease Severity.新型冠状病毒肺炎的肺部病理模式及其与疾病严重程度的临床相关性。
Indian J Crit Care Med. 2022 Dec;26(12):1285-1292. doi: 10.5005/jp-journals-10071-24364.
7
Diffuse alveolar damage (DAD) resulting from coronavirus disease 2019 Infection is Morphologically Indistinguishable from Other Causes of DAD.新型冠状病毒疾病 2019 感染导致的弥漫性肺泡损伤(DAD)在形态上与其他 DAD 病因无法区分。
Histopathology. 2020 Oct;77(4):570-578. doi: 10.1111/his.14180. Epub 2020 Sep 12.
8
Histopathological and virological features of lung, heart and liver percutaneous tissue core biopsy in patients with COVID-19: A clinicopathological case series.新型冠状病毒肺炎患者肺、心脏和肝脏经皮组织芯活检的组织病理学和病毒学特征:一项临床病理病例系列研究
Malays J Pathol. 2022 Apr;44(1):83-92.
9
Discrepancy between clinical criteria for diagnosing acute respiratory distress syndrome secondary to community acquired pneumonia with autopsy findings of diffuse alveolar damage.临床诊断社区获得性肺炎继发急性呼吸窘迫综合征的标准与尸检弥漫性肺泡损伤发现之间的差异。
Respir Med. 2011 Aug;105(8):1170-5. doi: 10.1016/j.rmed.2011.04.001. Epub 2011 May 12.
10
Megakaryocytes and platelet-fibrin thrombi characterize multi-organ thrombosis at autopsy in COVID-19: A case series.巨核细胞和血小板-纤维蛋白血栓是新冠病毒病尸检时多器官血栓形成的特征:病例系列
EClinicalMedicine. 2020 Jun 25;24:100434. doi: 10.1016/j.eclinm.2020.100434. eCollection 2020 Jul.

引用本文的文献

1
Effects of 12 mg vs. 6 mg dexamethasone on thromboembolism and bleeding in patients with critical COVID-19 - a post hoc analysis of the randomized, blinded COVID STEROID 2 trial.12毫克与6毫克地塞米松对重症新型冠状病毒肺炎患者血栓栓塞和出血的影响——随机、盲法COVID STEROID 2试验的事后分析
Ann Intensive Care. 2023 Mar 2;13(1):12. doi: 10.1186/s13613-023-01115-y.